» Articles » PMID: 30258399

Use of a Modified STROOP Test to Assess Color Discrimination Deficit in Parkinson's Disease

Overview
Journal Front Neurol
Specialty Neurology
Date 2018 Sep 28
PMID 30258399
Citations 3
Authors
Affiliations
Soon will be listed here.
Abstract

To objectively measure color vision dysfunction in idiopathic Parkinson's disease (iPD) using an easily administered, essentially free, modified Stroop test. Sixty-one iPD patients and 26 age-matched controls (HC) were enrolled after IRB approval and performed congruent (CST) and incongruent (IST) modified Stroop tests consisting of 40 words in 10 colors arranged in a 5 x 8 grid. The scorer was blinded to participant diagnosis. Errors on IST were defined as type 1 (written word reported rather than color) or type 2 (color reported different from the written word or its color). The iPD group and the control group completed testing with similar CST performance. On the IST, 75.4% of iPD patients had type 2 errors ( = 0.001, OR 4.907, 95%CI 1.838-13.097) compared to 38.5% HC, with a positive predictive value of 82%. The mean number of type 2 errors was also higher in the iPD group, even with MoCA scores as a covariate in the analysis. Type 1 errors were not significantly different between the groups. A univariate logistic regression model with age, gender, MoCA, normalized IST completion time and the presence/absence of type 2 errors also resulted in type 2 errors as the only significant factor in the equation ( = 0.026). The modified Stroop test incorporated into the clinical evaluation of a patient may provide a quick and inexpensive objective measure of a non-motor feature of iPD, which could help in the clinical diagnosis of iPD in conjunction with the motor assessments currently used by neurologists.

Citing Articles

Modulation of time in Parkinson's disease: a review and perspective on cognitive rehabilitation.

Honma M, Terao Y Front Psychiatry. 2024; 15:1379496.

PMID: 38686125 PMC: 11056500. DOI: 10.3389/fpsyt.2024.1379496.


Neuropsychological tests are useful for predicting comorbidities of idiopathic normal pressure hydrocephalus.

Kamohara C, Nakajima M, Kawamura K, Akiba C, Ogino I, Xu H Acta Neurol Scand. 2020; 142(6):623-631.

PMID: 32619270 PMC: 7689708. DOI: 10.1111/ane.13306.


Cortical Visual Performance Test Setup for Parkinson's Disease Based on Motion Blur Orientation.

Isenkul M Parkinsons Dis. 2019; 2019:3247608.

PMID: 30854187 PMC: 6377996. DOI: 10.1155/2019/3247608.

References
1.
Chang L, Lowe J, Ardiles A, Lim J, Grey A, Robertson K . Alzheimer's disease in the human eye. Clinical tests that identify ocular and visual information processing deficit as biomarkers. Alzheimers Dement. 2013; 10(2):251-61. DOI: 10.1016/j.jalz.2013.06.004. View

2.
Price M, Feldman R, Adelberg D, KAYNE H . Abnormalities in color vision and contrast sensitivity in Parkinson's disease. Neurology. 1992; 42(4):887-90. DOI: 10.1212/wnl.42.4.887. View

3.
Oh Y, Kim J, Chung S, Song I, Kim Y, Kim Y . Color vision in Parkinson's disease and essential tremor. Eur J Neurol. 2011; 18(4):577-83. DOI: 10.1111/j.1468-1331.2010.03206.x. View

4.
Fereshtehnejad S, Rios Romenets S, Anang J, Latreille V, Gagnon J, Postuma R . New Clinical Subtypes of Parkinson Disease and Their Longitudinal Progression: A Prospective Cohort Comparison With Other Phenotypes. JAMA Neurol. 2015; 72(8):863-73. DOI: 10.1001/jamaneurol.2015.0703. View

5.
Kertelge L, Bruggemann N, Schmidt A, Tadic V, Wisse C, Dankert S . Impaired sense of smell and color discrimination in monogenic and idiopathic Parkinson's disease. Mov Disord. 2010; 25(15):2665-9. DOI: 10.1002/mds.23272. View